Zivo Bioscience (ZIVO) Stock Statistics & Valuation Metrics

Zivo Bioscience has a market cap or net worth of $16.00M. The enterprise value is $14.92M.

Zivo Bioscience has 3,888,595 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zivo Bioscience’s return on equity (ROE) is 2.64 and return on invested capital (ROIC) is 316.76%.

The current PE Ratio of Zivo Bioscience is ―. Zivo Bioscience’s PEG ratio is 0.10.

In the last 12 months, Zivo Bioscience had revenue of 119.03K and earned -9.89M in profits. Earnings per share was -2.59.

In the last 12 months, operating cash flow was -2.49M and capital expenditures -4.00, giving a free cash flow of -2.49M billion.

Zivo Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Zivo Bioscience upcoming earnings date is Mar 15, 2024, Before Open (Confirmed).

Zivo Bioscience as a current ratio of 0.10, with Debt / Equity ratio of -16.84%

In the past 12 months, Zivo Bioscience has paid 0.00 in taxes.

Zivo Bioscience EV to EBITDA ratio is -3.44, with an EV/FCF ratio of -10.29.

Zivo Bioscience has $113.80K in cash and marketable securities with $569.66K in debt, giving a net cash position of -$455.86K billion.

Gross margin is 32.44%, with operating margin of -8278.84%, and net profit margin of -8311.12%.

The average price target for Zivo Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Hold